# OnCo record paper-joseph-novel-cancer-drugs-budget-impact-sri-lanka-ecancer-2025 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-joseph-novel-cancer-drugs-budget-impact-sri-lanka-ecancer-2025/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-joseph-novel-cancer-drugs-budget-impact-sri-lanka-ecancer-2025" ;
  schema:name "Budget impact of novel cancer drugs in Sri Lanka's state health system"@en ;
  schema:description "Funding every eligible patient with 42 novel cancer drugs in Sri Lanka would cost almost 300 million US dollars a year; restricting them to uses that meet a cost-effectiveness threshold would cost 6 to 13.2 million."@en ;
  schema:url <https://onco.cc/key-papers/paper-joseph-novel-cancer-drugs-budget-impact-sri-lanka-ecancer-2025/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  schema:citation <https://doi.org/10.3332/ecancer.2025.1941>, <https://pubmed.ncbi.nlm.nih.gov/40949479/> ;
  schema:sameAs <https://doi.org/10.3332/ecancer.2025.1941> ;
  schema:datePublished "2025"^^xsd:gYear ;
  schema:author "Joseph N, Peiris V, Bamunuarachchi V, et al." ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/lung-cancer/> ;
  onco:institutions <https://onco.cc/institutions/sri-lanka-ministry-of-health/> .
